Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Abbvie inc. crawled date : 2022 - 03 - 16 save search
RINVOQ® (upadacitinib) Receives FDA Approval for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis
Published: 2022-03-16 (Crawled : 22:00) - prnewswire.com
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.72%
H: 0.92%
C: 0.9%
rinvoq treatment fda fda approval approval active ulcerative colitis
Ulcerative Colitis Drug Market to Reach $10.59 Billion by 2028: The Brainy Insights
Published: 2022-03-16 (Crawled : 17:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 2.25%
H: 0.0%
C: 0.0%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: 0.0%
BHC | $8.6 -0.69% 0.0% 2.1M
|
Health Technology
|
| O: 2.55%
H: 2.44%
C: 2.35%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.4%
H: 0.2%
C: -0.29%
drug ulcerative colitis
Hematological Malignancies Emerging Therapeutics - A Global Industry Assessment with Insights & Projections by Therapeutic Type, Potential Pipeline Products, Indication, and Region, 2021-2031
Published: 2022-03-16 (Crawled : 14:30) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.46%
H: 3.49%
C: 3.49%
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: 2.07%
H: 1.62%
C: 1.56%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 1.23%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.26%
H: 0.31%
C: -0.39%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.4%
H: 0.2%
C: -0.29%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
GILD | News | $66.16 -1.15% -1.16% 6.4M
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: -1.19%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: -0.37%
ema therapeutics potential
Botulinum Toxin Market Size Worth $8.97Bn, Globally, by 2028 at 7.8% CAGR - Exclusive Report by The Insight Partners
Published: 2022-03-16 (Crawled : 11:00) - prnewswire.com
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.4%
H: 0.2%
C: -0.29%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
xin report
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.